4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-25-009816
Options or other derivatives
- See Remarks acquired 582,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sapir Alex See Remarks | 2025-01-24 | Grant or award · Stock option - Right to Buy | +582,000 | 582,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…